Lin, Mao <br/><br/>
Circulating tumor cell as a biomarker for evaluating allogenic NK cell immunotherapy on stage IV non-small cell lung cancer.  [electronic resource] 

 -  Immunology letters  11 2017 
 - 10-15 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-0542 
<br/><br/><label>Standard No.: </label>10.1016/j.imlet.2017.09.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, Neoplasm--metabolism<br/>Biomarkers, Tumor--metabolism<br/>Carcinoembryonic Antigen--metabolism<br/>Carcinoma, Non-Small-Cell Lung--diagnosis<br/>Female<br/>Humans<br/>Immunotherapy, Adoptive--methods<br/>Keratin-18--metabolism<br/>Killer Cells, Natural--immunology<br/>Lung Neoplasms--diagnosis<br/>Lymphocyte Count<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--metabolism<br/>Neoplasm Staging<br/>Neoplastic Cells, Circulating--pathology<br/>Prognosis<br/>Transplantation, Homologous<br/>Treatment Outcome